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Abstract
Background—By shifting a greater share of out-of-pocket medical costs to consumers, high-
deductible health plans (HDHP) might discourage use of essential outpatient services.
Objective—To examine the impact of a HDHP on outpatient visits and associated laboratory and 
radiology tests.
Research Design/Subjects—We used a pre-post with comparison group study design to 
examine the differential change in outpatient service utilization among 7953 adults who were 
switched from a traditional HMO plan to a HDHP compared with 7953 adults remaining in 
traditional plans. HDHP members had full coverage of preventive laboratory tests and modest 
copayments for outpatient visits, similar to controls, but faced full cost sharing under the 
deductible for radiology tests and laboratory tests not classified as preventive.
Results—Compared to controls, the HDHP group experienced moderate relative decreases in 
overall office visits (ratio of IRRs=0.91, or a 9% relative reduction; 95% confidence interval 0.88, 
0.94) and visits for higher (0.91; 0.85, 0.97) and lower-priority (0.89; 0.81, 0.99) chronic 
conditions. There were no significant differences in changes in visit rates for acute higher or 
lower-priority conditions (both 0.93; 0.86, 1.01) or preventive laboratory tests (0.97; 0.93, 1.02). 
HDHP members showed moderate relative reductions in the use of general laboratory tests (0.91; 
0.86, 0.97) but not radiology tests (0.97, 0.91, 1.03).
Conclusions—Chronic outpatient visits declined among HDHP members, although preventive 
labs and acute visits remained unchanged. HDHP patients with chronic illnesses who have more 
contact with the health care system might be more likely to reduce utilization because of increased 
exposure to costs associated with ambulatory visits.
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Introduction
The rapid expansion of high-deductible health plans (HDHPs) over the last decade is 
transforming the U.S. insurance marketplace, yet understanding of their impact on access to 
care remains limited. From 2006 to 2012, the percentage of covered employees enrolled in a 
plan with at least a $1000 deductible more than tripled from 10% to 34%.1 Among small 
firms, nearly 50% of workers were enrolled in HDHPs in 2012.1 The implementation of the 
Patient Protection and Affordable Care Act (ACA) will likely accelerate HDHP adoption as 
employers seek to control costs2 associated with current provisions3 in the law—such as the 
expansion of dependent coverage for children up to age 26 and the elimination of annual and 
lifetime coverage limits—and as millions of uninsured Americans who are mandated to buy 
coverage by 2014 opt for lower premium HDHPs through an employer or health insurance 
exchanges.4 Indeed, recent surveys confirm many employers expect to pass these costs onto 
consumers by raising cost sharing levels5,6 or offering a different plan6 such as a HDHP. 
Higher patient cost sharing, however, has raised concerns that HDHPs might lead to 
unintended reductions in routine, effective care.7
HDHPs shift costs to members by requiring full out-of-pocket payments for many services 
until an annual deductible has been met. Certain services, such as primary care visits, 
preventive screening, and prescription drugs, are often excluded from the deductible in such 
plans and, similar to traditional health plans, available for moderate or no cost sharing.1 For 
preventive services, this arrangement will likely become more prevalent as a result of the 
ACA, which requires most health plans to offer certain preventive care without deductibles 
or other cost sharing.1 In 2012 the average annual deductibles for HMO, PPO, and POS 
plans with deductible components ranged from $691 to $1014 for individuals and $1329 to 
$2163 for families.1 HDHPs with tax-advantaged health fund accounts, such as Health 
Reimbursement Accounts (HRAs) or Health Savings Accounts (HSAs), make up about half 
of the HDHP market and have significantly larger individual and family deductibles ($2086 
and $3924, respectively).1
The RAND Health Insurance Experiment established that cost sharing has substantial effects 
on the use of both essential and nonessential services and, in particular, that deductibles of 
all sizes can cause reductions in medical spending.8 More recent studies focusing on 
outpatient care have found that enrollment in HDHPs can lead to moderate reductions in the 
use of services with full cost sharing under the deductible, such as certain medications.9–12 
However, HDHPs that exempt and fully cover preventive services have been shown to 
preserve their use.13–15 A few studies have examined the impact of HDHPs on outpatient 
visits and found moderate to significant declines in visits following enrollment in a HDHP 
plan.11,16,17 However, the levels of cost sharing for outpatient visits were not clear in these 
studies,11,16,17 and two of the studies examined members who voluntarily chose HDHPs, 
possibly leading to selection bias.16,17
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No previous research has examined how HDHPs impact outpatient visits and commonly 
associated diagnostic tests that are both exempt and not exempt from the deductible. We 
investigated the impact of an employer-mandated switch from traditional HMOs to HDHPs 
on several types of outpatient services for acute and chronic conditions that had different 
cost sharing levels: office visits with modest copayments, preventive laboratory tests with 
first dollar coverage, and general lab tests and radiology tests with full cost sharing under a 
deductible. We hypothesized that the HDHP would have both intended effects such as 
preservation of fully covered preventive laboratory tests and reduction of lower priority 




On April 1, 2002 Harvard Pilgrim Health Care (HPHC), a nonprofit insurer in New England, 
began offering an HDHP to Massachusetts employers. The HDHP includes lower 
premiums18 and annual deductibles of $500–2000 for individual coverage and $1000–4000 
for family coverage.19 Full coverage for services included under the deductible begins for 
individual members after they reach their individual deductible, or for family members after 
either they reach their individual deductibles or the family’s combined expenses reach the 
family deductible. The HDHP provider network, referral policies, and copayment 
obligations for services exempt from the deductible are the same as for HPHC’s traditional 
HMO plans.
Most institutional services (e.g., emergency department visits and hospitalizations) and 
diagnostic procedures (e.g., radiology tests and general lab tests) are subject to the 
deductible in the HDHP.19 However, like traditional HMO plans, only modest copayments 
are charged for most outpatient visits, including routine exams, urgent care visits, and 
specialist consultations.19 These copayments must be paid whether or not the deductible has 
been met. Preventive services (e.g., immunizations, mammograms, and preventive lab tests) 
have first dollar coverage similar to traditional plans.19 The HDHPs also include an annual 
out-of-pocket maximum equal to twice the deductible amount but not less than $2000 for 
individuals and $4000 for families.19
Study Design and Sample
We employed a pre-post with comparison group study design to examine utilization rates of 
several outpatient services. Using previously established methods,13,20 we created a study 
cohort of HPHC members enrolled through Massachusetts employers that offered only a 
single type of HPHC insurance plan, reducing the influence of self-selection bias. The 
cohort comprised two groups of interest: an HDHP group and a control group. The HDHP 
group included members who were enrolled in traditional HMO plans during a one-year 
baseline period between April 1, 2001 and August 14, 2007 and then experienced an 
employer-mandated switch to an HDHP. The date of switch defined the index date. Each 
person in the HDHP group was randomly matched to eight contemporaneous HMO 
members based on adult/child status and whether the plan was purchased through an 
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independent broker. We assigned control members the same index date as their matched 
HDHP member. From this original cohort we selected 8916 HDHP members and 56978 
controls aged 18–63 years at baseline who were continuously enrolled for 12 months before 
and at least 12 months after the index date. To curtail the influence of outliers in our study, 
we excluded members whose baseline use of office visits, laboratory tests, or radiology tests 
was above the 99.5th percentile (n=259).
We used propensity score matching with 1:1 caliper matching to minimize employer-level 
selection effects and further improve the comparability of observed characteristics between 
the study groups.21,22 Variables in the propensity score model and the ensuing match 
included all variables that predicted being employed in a firm that switched to a HDHP, 
including age, sex, neighborhood socioeconomic characteristic, health status, individual or 
family plan status (assessed at index date),20 employer size (based on number of 
employees),20 baseline copayment level for outpatient, emergency department, and hospital 
visits, total member health plan costs at baseline, and secular changes. We performed an 
exact match on the characteristic of having one of four major chronic diseases associated 
with significant morbidity and mortality to ensure adequate representation in our sample: 
diabetes, hypertension, hyperlipidemia, and chronic pulmonary disease (asthma or chronic 
obstructive pulmonary disease). We also accounted for whether a plan was purchased 
through an independent broker (“association” plan) by doing an exact match on this 
characteristic given that these very small employers purchase health plans in a different 
manner (through small business associations rather than directly from Harvard Pilgrim) and 
we have slightly less information on enrollees (such as whether they had access to Health 
Reimbursement Arrangements).
To derive neighborhood-based measures of socioeconomic status, we linked members’ 
residential addresses to their 2000 U.S. Census block group, a subdivision of census tracts 
containing an average of 1000 individuals.20,23 We created previously established 
categorical variables of neighborhood poverty status and education levels20,24 and a 
composite variable for socioeconomic status.20 We defined a low socioeconomic status 
neighborhood as a census block group with greater than 10% of households below poverty 
level or 25% of adult household members with less than a high school education.20 To assess 
health status we used the Johns Hopkins Adjusted Clinical Groups (ACG) Score, a validated 
index of morbidity burden based on member age, sex and baseline ICD-9 diagnoses.25,26 
Relative to larger ACG scores, smaller scores indicate lower risk or greater health. We 
assumed that employer size, association status, and individual or family plan status were 
constant throughout the study.
We identified the four major chronic diseases based on the presence of either 2 outpatient or 
1 inpatient International Classification of Diseases, Ninth Revision, Clinical Modification 
(ICD-9) diagnoses during the baseline year, similar to previous studies.27–32 Our propensity-
matched sample comprised 7953 HDHP members and their matched controls, of whom 
1010 HDHP members and their matched controls had at least one of the four chronic 
diseases.
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We calculated the mean number of services used per member per study year for outpatient 
office visits, preventive lab tests, general lab tests, and radiology tests using HPHC medical 
claims data.
Using a taxonomy developed by Fenton et al.,33 we characterized each office visit into one 
of the following ICD-9 diagnostic categories: acute condition, chronic condition, 
symptomatic or ill-defined condition, mental illness, preventive or pregnancy-related care, 
vision or hearing disorder, and dermatologic condition. We used the Fenton taxonomy to 
further classify acute and chronic condition visits as higher- or lower-priority, with higher-
priority diseases being considered more likely to benefit from medical care than lower-
priority diseases.33 The classification system was originally derived from the Oregon 
Prioritized Health Services List, which included an evidence-based ranking of over 700 
diagnosis and treatment combinations according to the expected morbidity or mortality 
benefits of medical care.33,34
We identified preventive lab tests, general lab tests, and radiology tests in the claims data 
using Current Procedural Terminology (CPT®) 2008, Standard Edition codes.35 We 
included only claims that did not occur on dates of emergency department visits or 
hospitalizations. We identified preventive lab tests (that have full coverage under the HDHP) 
based on the HPHC benefit schedule. These included tests for HbA1C, microalbuminuria, 
cholesterol, lead exposure, routine urinalysis, routine hemoglobin, hepatitis C, prostate-
specific antigen, alpha-Fetoprotein, Group B streptococcus, sexually transmitted diseases, 
and HIV. We excluded fully covered Pap smear and fecal occult blood tests because we 
examined these in previous studies.13 The remaining pathology or laboratory claims were 
classified as general lab tests. Radiology tests comprised all outpatient radiologic procedures 
except for pregnancy ultrasound and mammography, which were fully covered by the 
HDHP.
To assess which specific services might be affected by the plan switch, we identified the top 
ten most common services in each outcome category at baseline, according to ICD-9 
Clinical Classification Software (CCS) categories36 (visits) and CPT® codes (lab and 
radiology tests). The top ten reasons for office visits (routine exam, affective diagnosis, other 
mental condition, upper respiratory infection, anxiety disorder, hypertension, connective 
tissue disorder, back problem, skin diagnosis, and joint disorder) accounted for 47.0% of all 
baseline visits, while the top ten preventive lab tests, general lab tests, and radiology tests 
accounted for 81.8%, 41.1%, and 48.6% of their respective baseline totals. Due to their 
clinical importance, we also identified the ten most common chronic high- and lower-
priority visit reasons, which accounted for 63.4% and 69.0% of their respective baseline 
totals.
The average total costs per test for the top ten general lab and radiology tests (i.e., tests with 
full cost sharing for HDHP members) during baseline were $11.80 and $49.07 (maximum: 
$261.80 and $768.36), respectively. Mean outpatient (office visit) copayment levels for the 
HDHP group were $15.20 during baseline and $20.00 in the follow-up year, while the 
corresponding copayments were $15.05 and $15.74 for the control group.
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We compared baseline characteristics of the study groups using t tests and chi-square tests. 
We tested whether changes in annual rates after the index date were statistically significant 
using Poisson regression and generalized estimating questions to control for correlations 
between the measurements for each sample member before and after the plan switch. The 
analytic model produced incidence rate ratios (IRRs) by comparing the mean rates in the 
first year after the index date and the baseline year. We calculated the differential change in 
the incidence rate between study groups by examining the interaction between study group 
and year. The exponentiated parameter estimate for the interaction term can be interpreted as 
the ratio of IRRs. For example, a ratio of IRRs of 0.89 would indicate an 11% relative 
reduction in use among the HDHP members compared to controls from baseline to follow-
up.
As a post-hoc analysis, we calculated the relative change in general lab tests per visit to 
investigate whether reductions were primarily driven by declines in visits or fewer tests per 
visit.
All models were left unadjusted because our propensity score match generated study groups 
that were closely matched at baseline (see Appendix, supplemental digital content 1, which 
further describes our matching and analytic approach). The analyses were conducted using 
SAS version 9.3 (SAS Institute, Cary, North Carolina) and we specified an a priori statistical 
significance level of P<0.05.
Results
Baseline Characteristics
Table 1 shows similar demographic, health, and plan characteristics between the HDHP and 
control groups. Both study groups had a mean age of 44.8 and were balanced by gender. 
Most members in each group were in family plans and employed by small firms. About half 
of each group purchased insurance through an association plan. The mean ACG score and 
the proportion of members with diabetes, hypertension, hyperlipidemia, or chronic 
pulmonary disease were comparable between study groups. Most members in each group 
resided in neighborhoods characterized by higher socioeconomic status. About one-third of 
members in both groups had baseline outpatient (office visit) copayment levels greater than 
$15 and inpatient copayment levels greater than $350.
Annual Changes in Utilization of Outpatient Services
Results from the Poisson regression models are shown in Table 2. HDHP members 
experienced a 9% relative reduction in the use of all office visits (ratio of IRRs=0.91; 95% 
CI 0.88, 0.94). The HDHP group showed similar relative reductions in visits for chronic 
higher-priority conditions (0.91; 0.85, 0.97), chronic lower-priority conditions (0.89; 0.81, 
0.99), symptomatic or ill-defined conditions (0.88; 0.82, 0.95), and preventive or 
reproductive-related care (0.92; 0.87, 0.98) compared to controls. Changes in mean visits for 
the remaining Fenton categories including acute higher- and lower-priority conditions (0.93; 
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0.86,1.01 and 0.93; 0.86, 1.01, respectively) were not statistically different between the 
study groups.
HDHP members experienced a significant 9% relative decline in the use of all general lab 
tests (0.91; 0.86, 0.97) but no detectable changes in preventive lab tests (0.97; 0.93, 1.02) or 
radiology tests (0.97; 0.91, 1.03). The number of general labs per visit did not change for 
HDHP members relative to controls (data not shown).
Discussion
The growing prevalence of HDHPs has raised concerns about their impact on essential care. 
Our study investigated the effect of HDHPs on the use of outpatient visits and associated 
diagnostic services. Although exempting services from full cost sharing appeared to preserve 
the use of outpatient visits for acute care and preventive lab tests, relative rates of visits for 
chronic, symptomatic or ill-defined conditions, and preventive or reproductive-related care 
declined, driving a 9% relative reduction in outpatient visits. Full cost sharing was 
associated with reduced use of general labs but not radiology tests.
Our findings suggest that enrollment in an HDHP was associated with both intended and 
unintended consequences, largely consistent with previous research on the effects of 
increased cost sharing.8 Unchanged rates of high-priority acute visits and preventive labs 
indicate these services can be preserved under HDHPs that exempt them from the 
deductible. Relative reduction in lower-priority chronic visits such as upper respiratory or 
osteoarthritic conditions may indicate potential cost savings without impacts on quality. In 
contrast, relative reductions in chronic higher-priority visits for conditions such as 
hypertension and asthma might represent a deferral of essential care that could increase 
future morbidity and costs. We are unable to conclude whether the observed relative changes 
in general lab test utilization were appropriate or inappropriate, since this assessment 
requires detailed clinical information not available in claims data.
Our study provides evidence of indirect reductions in health care services not subject to the 
deductible. In particular, office visits for HDHP members were selectively excluded from the 
deductible and available for copays of $20, yet relative reductions occurred in rates of 
chronic visits, visits associated with symptomatic or ill-defined conditions, and preventive or 
reproductive-related care. One hypothesis to be tested in future research is that members 
with these conditions incurred higher costs from associated services (such as general labs 
and radiology tests) following transition to HDHPs, which led indirectly to subsequent 
reductions in future visits. Similarly, it would be useful to examine whether the unexpected 
decline in visits for preventive or reproductive-related care was due to costs from services 
associated with reproductive care visits (for example, contraceptive, prenatal, or menopause 
services).
HDHP members preserved preventive lab tests with first dollar coverage despite reductions 
in overall outpatient visits, possibly indicating awareness of the "value-based" incentives of 
the HDHP. Reductions in general lab tests (which were subject to the deductible) could 
similarly indicate price awareness, but reasons for this reduction deserve scrutiny and raise 
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the general question of whether patterns we detected were primarily patient- or provider 
driven. A key policy and research question is whether HDHPs can stimulate "activated 
consumers" who selectively maintain or increase high-value care at the expense of low value 
care. Outpatient care is a good setting in which to examine this because patients generally 
have discretion in undergoing the types of services we examined. Because we detected 
reductions in care, a preliminary question is whether these were primarily patient or provider 
driven. Because HDHP members had financial incentives to reduce utilization after the index 
date whereas their providers did not, any reductions were likely driven by HDHP patients. 
To further understand the reductions, it is helpful to consider visits and testing as two 
distinct categories because of differing patient-provider influences on utilization decisions. 
Reductions in outpatient visits would be patient-driven almost by definition because patients 
must usually decide independently whether to present (although decision support resources 
such as telephone triage are sometimes available). Here, we did not find evidence that 
patients made distinctions in visits by appropriateness given the similar level of reductions in 
both high- and low-priority care (Table 2). Outpatient testing usually involves joint patient-
provider decisions at the point of care, so that the reductions we detected could indicate 
either that patients made a decision not to undergo testing or experienced reductions only 
because outpatient visits declined. Our analyses showing that general lab tests per visit did 
not decline in the HDHP group relative to the control group suggests that reductions were 
caused by outpatient visit reductions, not point-of-care consumerism (see Appendix, 
supplemental digital content 2, which includes the test per visit results and a broader 
discussion about patient decision-making). HDHPs therefore might primarily have a 
"gatekeeper" effect on certain outpatient services via reducing contact with the system.
Contrary to our hypothesis, HDHP members did not experience significant reductions in the 
use of radiology tests, relatively expensive services that were subject to full cost sharing. 
This result might be related to preservation of certain types of outpatient visits (e.g., if such 
tests occurred predominantly during acute care visits), to patients’ perceptions of the relative 
importance of radiology tests, or to the fact that many physicians order films to be 
completed and interpreted while patients wait.
Previous studies of HDHPs and outpatient care have also found that HDHPs protect the use 
of preventive services that have first dollar coverage, such as breast,13,14 cervical,13–15 and 
colorectal cancer screening;13,15 child wellness visits;15 and diabetic monitoring.14 A recent 
large study found small but statistically significant reductions in preventive care, including 
immunizations, cancer screening, and diabetes HbA1c measurement, following HDHP 
enrollment, but cost sharing levels for these services were uncertain and study members 
could have selected into HDHPs.37 In addition, while HDHP enrollment has been shown to 
reduce the use of certain medications that fall under the deductible,9–12 utilization is 
generally preserved for exempted medications that have only modest three-tiered 
copayments.38 This evidence, along with the findings of our study, may suggest that patients 
are able to maintain rates of desired services such as preventive tests with modest cost 
sharing, despite having fewer office visits. Other studies that have examined the impact of 
HDHPs on outpatient visits show moderate,11,16,17 if temporary,17 reductions in use, 
although the cost sharing requirements of visits in these studies were not clear.
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Three major implications emerge from this research. First, HDHPs that exempt outpatient 
care from the deductible while requiring modest ($20) copayments might reduce visits for 
chronic conditions. Further research should examine how such patterns affect health 
outcomes and whether chronic visits decline due to more frequent exposure of chronically ill 
patients to costs associated with outpatient visits. Second, utilization was preserved for 
services with first-dollar coverage, such as preventive labs. Policymakers could consider 
selectively extending first-dollar coverage to additional high-value outpatient services, such 
as chronic higher-priority visits and associated general labs, in order to maintain use. Finally, 
the relative preservation of radiology tests despite full cost sharing is contrary to the 
generally accepted view that HDHPs broadly reduce services subject to the deductible. 
Future studies should examine radiology utilization in detail and attempt to differentiate 
between appropriate and discretionary use.
Our study has several potential limitations. First, we examined broad categories of services 
and the results may not be generalizable to specific services in each category. However, by 
examining the most common services in each category, we shed light on the services that 
most contributed to our results. Furthermore, the study’s comprehensive scope included 
outcomes absent from previous work, such as general lab and radiology test use. Second, we 
had a limited ability to understand the reasons for general lab or radiology test use, and thus 
could not comment about appropriateness of changes in utilization. Third, the findings from 
our controlled pre-post study could be biased if HDHP members and matched controls 
experienced different trends in use during the baseline period or if the control group 
preferentially includes members whose employers chose traditional plans because they 
anticipated higher utilization. However, we inspected quarterly baseline trends in use for all 
outcomes and found that the study groups’ trajectories were always similar. Finally, our 
findings may not be generalizable to populations with other demographic or health 
compositions, or HDHPs with different cost sharing structures. However, because we studied 
a typical HDHP using a strong study design, our findings should be informative for similar 
commercially insured and relatively high socioeconomic status populations, in addition to 
employers newly providing HDHPs under the Affordable Care Act (see Appendix, 
supplemental digital content 3, which includes further discussion about the issue of 
generalizability).
Enrollment in an HDHP was associated with both intended and unintended changes in 
patterns of outpatient health care utilization. In particular, higher-priority chronic outpatient 
visits declined while no changes were detectable in preventive labs and acute visits. Future 
studies should examine whether chronic visits decline due to more frequent exposure of 
chronically ill patients to costs associated with outpatient visits, follow a larger, nationally 
representative cohort over a longer period, and examine associated changes in important 
proxy outcomes such as emergency department and hospital visits.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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